TearCare in Young Adults (NCT07579156) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
TearCare in Young Adults
United States45 participantsStarted 2026-08-01
Plain-language summary
This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs at Day 28.
Who can participate
Age range
18 Years – 29 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥18 years but \<30 years of age
. Non-invasive Keratograph break-up time (NIKBUT) \<10 seconds in at least one eye
. Meibomian gland secretion score (MGSS) ≤23 for 15 glands in at least one eyelid
. OSDI ≥23
Exclusion criteria
. Contact lens wear within two weeks of study enrollment or planned during study period
. Habitual visual acuity worse than 0.30 logMAR (Snellen equivalent of 20/40) in either eye
. Previous or current diagnosis of any autoimmune condition
. Use of any of the following medications within 60 days of enrollment:
. Topical ophthalmic cyclosporine (including but not limited to Restasis®, Cequa®, Vevye®, generic, or compounded versions)
. Xiidra®
. Miebo®
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
OSDI AT 4 WEEKS
Timeframe: Baseline to 4 weeks
2
Non-Invasive Keratograph Break-Up Time(NIKBUT) at 4 weeks